Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study
Sign Up to like & getrecommendations! Published in 2017 at "Trials"
DOI: 10.1186/s13063-017-1825-7
Abstract: BackgroundWhite matter hyperintensities (WMHs) are commonly seen on in brain imaging and are associated with stroke and cognitive decline. Therefore, they may provide a relevant intermediate outcome in clinical trials. WMH can be measured as… read more here.
Keywords: volume; year; intermediate outcome; size ... See more keywords